Terry Kelly
Corporate Officer/Principal chez VOLITIONRX LIMITED
Profil
Terry Kelly is currently the Chief Innovation Officer at VolitionRX Ltd.
Prior to this, she worked as the Director of Research and Development at Active Motif, Inc. Ms. Kelly holds a doctorate degree from the University of California, Los Angeles.
Postes actifs de Terry Kelly
| Sociétés | Poste | Début |
|---|---|---|
| VOLITIONRX LIMITED | Corporate Officer/Principal | 01/03/2020 |
Anciens postes connus de Terry Kelly
| Sociétés | Poste | Fin |
|---|---|---|
Active Motif, Inc.
 Active Motif, Inc. BiotechnologyHealth Technology Active Motif, Inc. develops and distributes molecular biology-based research tools and kits that help researchers elucidate the function, regulation and interactions of the genes and their encoded proteins. Its products include New TransAM, Methylated Histones, and Histone Purification Mini Kit. The company was founded in 1999 and is located in Carlsbad, CA. | Directeur Technique/Scientifique/R&D | - |
Formation de Terry Kelly
| University of California, Los Angeles | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VOLITIONRX LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Active Motif, Inc.
Active Motif, Inc. BiotechnologyHealth Technology Active Motif, Inc. develops and distributes molecular biology-based research tools and kits that help researchers elucidate the function, regulation and interactions of the genes and their encoded proteins. Its products include New TransAM, Methylated Histones, and Histone Purification Mini Kit. The company was founded in 1999 and is located in Carlsbad, CA. | Health Technology |
